Defining the incidence and risk factors of colistin-induced acute kidney injury by KDIGO criteria

@inproceedings{Shields2017DefiningTI,
  title={Defining the incidence and risk factors of colistin-induced acute kidney injury by KDIGO criteria},
  author={Ryan K. Shields and Rohit Anand and Lloyd G. Clarke and Julie Ann Paronish and Matthew Weirich and Hanna Perone and Jake Kieserman and Henry R Freedy and Christina Andrzejewski and H{\'e}ctor Reyes Bonilla},
  booktitle={PloS one},
  year={2017}
}
BACKGROUND Acute kidney injury (AKI) remains a treatment-limiting toxicity of colistin. Recently developed clinical practice guidelines from the Kidney Disease: Improving Global Outcomes (KDIGO) group have harmonized definitions of AKI, but have not been widely applied to patients receiving colistin. METHODS We retrospectively defined AKI by KDIGO definitions among adult patients receiving intravenous colistin for ≥ 3 days. Risk factors for AKI within 48 hours and 7 days of initiating… CONTINUE READING
1 Citations
34 References
Similar Papers

References

Publications referenced by this paper.
Showing 1-10 of 34 references

A review on colistin nephrotoxicity

  • A OrdooeiJavan, S Shokouhi, Z Sahraei
  • European journal of clinical pharmacology
  • 2015

Similar Papers

Loading similar papers…